• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,886.91 -416.72
( -0.54%)
Global Indices
Nasdaq
49,198.35 -53.37
(-0.11%)
Dow Jones
7,195.79 9.71
(0.14%)
Hang Seng
59,839.06 -698.30
(-1.15%)
Nikkei 225
10,332.91 11.82
(0.11%)
Forex
USD-INR
93.91 -0.14
(-0.15%)
EUR-INR
110.02 0.03
(0.03%)
GBP-INR
127.00 0.16
(0.13%)
JPY-INR
0.59 0.00
(-0.03%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
99.2482659
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
95.32
415996.7
EPS(TTM)
Face Value()
Div & Yield %
18.19
1
0.92
 

Marsons bags Rs 15-cr order from Inox Solar
Apr 18,2026
The order is scheduled to be executed within a period of 3-6 months. The company clarified that neither its promoters nor promoter group entities have any interest in the awarding entity, and the transaction does not qualify as a related-party transaction.

Marsons is engaged in the business of manufacturing, trading & servicing of transformer, transformer goods & other rental income.

The company’s consolidated net profit rose 2.5% to Rs 6.48 crore on 4% increase in net sales to Rs 45.94 crore in Q3 FY26 over Q3 FY25.

The counter shed 0.83% to end at Rs 156 on the BSE.